If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
420.00    2.00 (0.48%)
Bid:
420.00
Ask:
422.00
Spread: 2.00 (0.476%)
Market Cap: £532.88m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Statement re Shareholder Engagement

20 Dec 2022 07:00

RNS Number : 2208K
North Atlantic Smlr Co Inv Tst PLC
20 December 2022
 

North Atlantic Smaller Companies Investment Trust PLC

(the "Company")

 

20 December 2022

 

 

Further to the Company's Results of Annual General Meeting announcement on 21 June 2022, the Company announced that over 20% of shareholders voting on resolution 14 concerning the waiver of Rule 9 had voted against the resolution. Resolution 14 was put to the Meeting as a resolution of the independent shareholders of the Company. As a result, 9,455,336 of the ordinary shares in issue were eligible to vote on this resolution, these shares not being held by the Concert Party (as defined in the Notice of AGM). The waiver of Rule 9 granted by Resolution 14 permits the Concert Party's interest in the Company's shares to increase from 30.78% to a maximum of 34.21% (in each case representing 4,205,664 ordinary shares) as a result of the share buyback authorised by Resolution 12 without requiring the Concert Party to make a mandatory offer for the other shareholders' shares. 

 

Under the FRC's UK Corporate Governance Code, companies receiving such a vote against a resolution should publish, no later than six months after the shareholder meeting, an update on the views received from shareholders and actions taken by the Company. 

 

Following an extensive analysis of the Company's Shareholder Register, the Company have established that the majority of the voting shares received against the waiver of Rule 9 are held in nominee accounts, many of which rely on shareholder advisory consultants to determine their voting. This means that underlying investors are recommended to vote against share buybacks in principle as the shareholder advisory consultants are concerned about what they see as the Concert Party's potential creeping control of the Company. Whilst this is a valid concern for a trading company, the Directors do not believe this is so for an investment trust.

 

The Board have been working to positively engage with the underlying Shareholders and are accelerating their Investor Relations efforts in this regard and continue to do so. The Directors expect to commence a further outreach campaign to engage with any dissenting Shareholders in the coming months and to help resolve any concerns they may have. The outcome of this initiative will be published in the Company's Annual Report next spring. In the meantime, the Board believe that it is overwhelmingly in the best interest of all Shareholders that the buyback programme continues. 

 

 

 

Contact:

Kin Company Secretarial Limited, Company Secretary

020 8819 6486

companysecretary@kincosec.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQKLFFLLLLFBD
Date   Source Headline
26th Jun 20182:50 pmRNSResult of AGM
13th Jun 20184:35 pmRNSHolding(s) in Company
11th Jun 201810:49 amRNSNet Asset Value(s)
23rd May 201810:19 amRNSAnnual Financial Report
14th May 201812:34 pmRNSNet Asset Value(s)
11th May 20184:56 pmRNSFinal Results
27th Apr 201810:15 amRNSHolding(s) in Company
18th Apr 20182:38 pmRNSHolding(s) in Company
11th Apr 201810:47 amRNSNet Asset Value(s)
15th Mar 20184:28 pmRNSNet Asset Value(s)
15th Feb 20183:02 pmRNSDirector/PDMR Shareholding
12th Feb 201811:28 amRNSNet Asset Value(s)
24th Jan 201812:08 pmRNSHolding(s) in Company
22nd Jan 201810:35 amRNSHolding(s) in Company
16th Jan 201810:29 amRNSNet Asset Value(s)
12th Dec 20171:05 pmRNSNet Asset Value(s)
14th Nov 201711:04 amRNSNet Asset Value(s)
31st Oct 20175:11 pmRNSDirectorate Change
16th Oct 201711:20 amRNSNet Asset Value(s)
13th Sep 201711:09 amRNSHalf-year Report
12th Sep 20172:05 pmRNSNet Asset Value(s)
15th Aug 201712:17 pmRNSNet Asset Value(s)
27th Jun 20174:20 pmRNSAGM Statement
23rd Jun 20174:42 pmRNSNet Asset Value(s)
1st Jun 201711:21 amRNSAnnual Financial Report
23rd May 20174:30 pmRNSDirector/PDMR Shareholding
23rd May 201710:57 amRNSNet Asset Value(s) - Replacement
19th May 20174:23 pmRNSFinal Results
15th May 201712:57 pmRNSNet Asset Value(s)
18th Apr 20172:02 pmRNSNet Asset Value(s)
5th Apr 201711:36 amRNSDirector/PDMR Shareholding
3rd Apr 20175:20 pmRNSDirector/PDMR Shareholding
30th Mar 201712:20 pmRNSDirector/PDMR Shareholding
28th Mar 201710:43 amRNSDirector/PDMR Shareholding
27th Mar 20176:10 pmRNSDirector/PDMR Shareholding
21st Mar 20171:21 pmRNSDirector/PDMR Shareholding
15th Mar 201710:20 amRNSNet Asset Value(s)
7th Mar 20174:09 pmRNSDirector/PDMR Shareholding
15th Feb 201711:42 amRNSNet Asset Value(s)
18th Jan 20172:46 pmRNSNet Asset Value(s)
11th Jan 201710:52 amRNSTransaction in Own Shares
13th Dec 201610:11 amRNSNet Asset Value(s)
14th Nov 201612:59 pmRNSNet Asset Value(s)
14th Nov 201612:26 pmRNSTransaction in Own Shares
13th Oct 20161:46 pmRNSNet Asset Value(s)
6th Oct 20162:50 pmRNSNotification of Major Interest in Shares
15th Sep 201611:31 amRNSNet Asset Value(s)
14th Sep 20162:40 pmRNSHalf-year Report
10th Aug 201612:17 pmRNSNet Asset Value(s)
13th Jul 201610:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.